Works matching IS 03125963 AND DT 2023 AND VI 62 AND IP 4

Results: 11

Correction to: Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 653, doi. 10.1007/s40262-023-01236-4

By:

Agersnap, Mikkel Askjær;
Sonne, Kim;
Knudsen, Kim Mark;
Sulowicz, Wladyslaw

Publication type:

Article

External Evaluation of Population Pharmacokinetic Models for Precision Dosing: Current State and Knowledge Gaps.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 533, doi. 10.1007/s40262-023-01233-7

By:

El Hassani, Mehdi;
Marsot, Amélie

Publication type:

Article

Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 599, doi. 10.1007/s40262-023-01228-4

By:

Yang, Eunsol;
Ji, Sang Chun;
Jang, In-Jin;
Lee, SeungHwan

Publication type:

Article

Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 559, doi. 10.1007/s40262-023-01225-7

By:

Appeldoorn, T. Y. J.;
Munnink, T. H. Oude;
Morsink, L. M.;
Hooge, M. N. Lub-de;
Touw, D. J.

Publication type:

Article

Assessing the Impact of Immunogenicity and Improving Prediction of Trough Concentrations: Population Pharmacokinetic Modeling of Adalimumab in Patients with Crohn's Disease and Ulcerative Colitis.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 623, doi. 10.1007/s40262-023-01221-x

By:

Ponce-Bobadilla, Ana Victoria;
Stodtmann, Sven;
Chen, Mong-Jen;
Winzenborg, Insa;
Mensing, Sven;
Blaes, Jonas;
Haslberger, Tobias;
Laplanche, Loic;
Dreher, Ingeborg;
Mostafa, Nael M.

Publication type:

Article

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions for Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor (FXR) Agonist.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 609, doi. 10.1007/s40262-023-01214-w

By:

Younis, Islam;
Weber, Elijah;
Nelson, Cara;
Kirby, Brian J.;
Shen, Gong;
Xiao, Deqing;
Watkins, Timothy R.;
Othman, Ahmed A.

Publication type:

Article

Clinical Pharmacokinetics and Pharmacodynamics of CSL112.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 541, doi. 10.1007/s40262-023-01224-8

By:

Ortega-Paz, Luis;
Giordano, Salvatore;
Capodanno, Davide;
Mehran, Roxana;
Gibson, C. Michael;
Angiolillo, Dominick J.

Publication type:

Article

Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 635, doi. 10.1007/s40262-023-01223-9

By:

van Hout, Marloes;
Forte, Pablo;
Jensen, Thomas B.;
Boschini, Cristina;
Bækdal, Tine A.

Publication type:

Article

Pharmacokinetics, Safety, and Tolerability of Glepaglutide, a Long-Acting GLP-2 Analog, in Subjects with Renal Impairment.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 645, doi. 10.1007/s40262-023-01215-9

By:

Agersnap, Mikkel Askjær;
Sonne, Kim;
Knudsen, Kim Mark;
Sulowicz, Wladyslaw

Publication type:

Article

Population Pharmacokinetics and Dosing Simulations of Ampicillin and Sulbactam in Hospitalised Adult Patients.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 573, doi. 10.1007/s40262-023-01219-5

By:

Setiawan, Eko;
Cotta, Menino Osbert;
Abdul-Aziz, Mohd-Hafiz;
Widjanarko, Doddy;
Sosilya, Hernycane;
Lukas, Dwi Lily;
Wallis, Steven C.;
Parker, Suzanne;
Roberts, Jason A.

Publication type:

Article

Population Pharmacokinetics and Exposure–Response Analysis for the Phase 3 COSMIC-311 Trial of Cabozantinib for Radioiodine-Refractory Differentiated Thyroid Cancer.

Published in:

Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 587, doi. 10.1007/s40262-023-01210-0

By:

Ly, Neang S.;
Li, Jing;
Faggioni, Raffaella;
Roskos, Lorin K.;
Brose, Marcia S.

Publication type:

Article